Literature DB >> 17878650

Isolated reversible splenial lesion in adult meningitis: a case report and review of the literature.

Momo Tani1, Shihoko Natori, Kazuyuki Noda, Kenji Fujishima, Nobutaka Hattori, Yoshikuni Mizuno, Yasuyuki Okuma.   

Abstract

We report the rare case of a 38-year-old man who suffered from aseptic meningitis. Brain magnetic resonance imaging showed an ovoid lesion with a high signal intensity on T2- and diffusion-weighted images in the splenium of the corpus callosum that completely disappeared within a week. There were no symptoms or signs associated with the lesion, and the prognosis was good. Although rare in adult patients, awareness of a reversible splenial lesion in meningoencephalitis is important.

Entities:  

Mesh:

Year:  2007        PMID: 17878650     DOI: 10.2169/internalmedicine.46.6457

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  A Reversible Lesion of the Corpus Callosum Associated With Bacterial Meningitis.

Authors:  Yasmine Mimouni; Rim Tazi; Amal Miqdadi; Sarra Saaf; Asmaa Hazim
Journal:  Cureus       Date:  2022-06-03

2.  Unusual combination of reversible splenial lesion and meningitis-retention syndrome in aseptic meningomyelitis.

Authors:  Nida Tascilar; Hande Aydemir; Ufuk Emre; Aysun Unal; H Tugrul Atasoy; Sureyya Ekem
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

3.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report.

Authors:  Koki Kosami; Tsuneaki Kenzaka; Yuka Sagara; Kensuke Minami; Masami Matsumura
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090

4.  Reversible splenial lesion syndrome associated with lobar pneumonia: Case report and review of literature.

Authors:  Chunrong Li; Xiujuan Wu; Hehe Qi; Yanwei Cheng; Bing Zhang; Hongwei Zhou; Xiaohong Lv; Kangding Liu; Hong-Liang Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.